Concepedia

Kirsten J. Horndasch

KJ

3

Publications

276

Citations

3

H-Index

2000

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Kirsten J. Horndasch is an author at Dana-Farber Cancer Institute.

Publications per year

2000–2001

3

Publications

3

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

Cornelius Schmaltz, Önder Alpdoğan, Kirsten J. Horndasch et al. · Blood · 2001 · 183 citations · Full text

Fas-Deficient <i>lpr</i> Mice Are More Susceptible to Graft-Versus-Host Disease

Marcel R.M. van den Brink, Ellen Moore, Kirsten J. Horndasch et al. · The Journal of Immunology · 2000 · 69 citations

Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.

Marcel R.M. van den Brink, Ellen Moore, Kirsten J. Horndasch et al. · PubMed · 2000 · 24 citations

Rows per page

1–3 of 3